Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
2,077,650
-
Share change
-
+60,276
-
Total reported value
-
$32,385,016
-
Put/Call ratio
-
0.17%
-
Price per share
-
$15.59
-
Number of holders
-
31
-
Value change
-
+$1,424,765
-
Number of buys
-
20
-
Number of sells
-
6
Institutional Holders of ZYNERBA PHARMACEUTICALS INC - COM (ZYNE) as of Q4 2016
As of 31 Dec 2016,
ZYNERBA PHARMACEUTICALS INC - COM (ZYNE) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,077,650 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, Cormorant Asset Management, LLC, VANGUARD GROUP INC, J. Goldman & Co LP, BRIDGEWAY CAPITAL MANAGEMENT INC, Cheyne Capital Management (UK) LLP, GEODE CAPITAL MANAGEMENT, LLC, PUTNAM INVESTMENTS LLC, AUXIER ASSET MANAGEMENT, and NORTHERN TRUST CORP.
This page lists
31
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.